BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukunaga K, Ohda Y, Hida N, Iimuro M, Yokoyama Y, Kamikozuru K, Nagase K, Nakamura S, Miwa H, Matsumoto T. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. J Gastroenterol Hepatol. 2012;27:1808-1815. [PMID: 22775479 DOI: 10.1111/j.1440-1746.2012.07215.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Khan I, Samson SE, Grover AK. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. Med Princ Pract 2017;26:201-17. [PMID: 28278495 DOI: 10.1159/000468988] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
2 Sebepos-rogers GM, Rampton DS. Herbs and Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2017;46:809-24. [DOI: 10.1016/j.gtc.2017.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol 2015; 21(15): 4466-4490 [PMID: 25914456 DOI: 10.3748/wjg.v21.i15.4466] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
4 Holleran G, Scaldaferri F, Gasbarrini A, Currò D. Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials. Phytother Res 2020;34:77-93. [PMID: 31701598 DOI: 10.1002/ptr.6517] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
5 Sałaga M, Zatorski H, Sobczak M, Chen C, Fichna J. Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review. Curr Treat Options Oncol 2014;15:405-20. [PMID: 24792017 DOI: 10.1007/s11864-014-0288-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
6 Mosli MH, Parker CE, Nelson SA, Baker KA, MacDonald JK, Zou GY, Feagan BG, Khanna R, Levesque BG, Jairath V. Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev 2017;5:CD011256. [PMID: 28542712 DOI: 10.1002/14651858.CD011256.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
7 Ozawa K, Mori D, Hatanaka A, Sawano T, Nakatani J, Ikeya Y, Nishizawa M, Tanaka H. Comparison of the anti-colitis activities of Qing Dai/Indigo Naturalis constituents in mice. J Pharmacol Sci 2020;142:148-56. [PMID: 32033881 DOI: 10.1016/j.jphs.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kawai S, Iijima H, Shinzaki S, Hiyama S, Yamaguchi T, Araki M, Iwatani S, Shiraishi E, Mukai A, Inoue T, Hayashi Y, Tsujii M, Motooka D, Nakamura S, Iida T, Takehara T. Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol 2017;52:904-19. [PMID: 27900483 DOI: 10.1007/s00535-016-1292-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
9 Yang K, Tang ZP. Suppositories for treatment of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2014; 22(36): 5648-5652 [DOI: 10.11569/wcjd.v22.i36.5648] [Reference Citation Analysis]
10 Ng SC, Lam YT, Tsoi KK, Chan FK, Sung JJ, Wu JC. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:854-863. [PMID: 23981095 DOI: 10.1111/apt.12464] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 9.0] [Reference Citation Analysis]
11 Urushikubo J, Yanai S, Nakamura S, Kawasaki K, Akasaka R, Sato K, Toya Y, Asakura K, Gonai T, Matsumoto T. Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series. Intern Med 2019;58:2299-304. [PMID: 31118381 DOI: 10.2169/internalmedicine.2446-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
12 Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 2015;21:4466-4490. [PMID: 25914456 DOI: 10.3748/wjg.v21.i15.4446] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Naganuma M. Treatment with indigo naturalis for inflammatory bowel disease and other immune diseases. Immunol Med 2019;42:16-21. [PMID: 31034341 DOI: 10.1080/25785826.2019.1599158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Gu S, Xue Y, Gao Y, Shen S, Zhang Y, Chen K, Xue S, Pan J, Tang Y, Zhu H, Wu H, Dou D. Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking. Sci Rep 2020;10:15204. [PMID: 32938944 DOI: 10.1038/s41598-020-71030-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
15 Hao Y, Nagase K, Hori K, Wang S, Kogure Y, Fukunaga K, Kashiwamura S, Yamamoto S, Nakamura S, Li J, Miwa H, Noguchi K, Dai Y. Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair. Evid Based Complement Alternat Med 2014;2014:569587. [PMID: 25120575 DOI: 10.1155/2014/569587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang L, Luo H, Tan D, Zhang S, Zhong Z, Wang S, Vong CT, Wang Y. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021;92:153709. [PMID: 34560518 DOI: 10.1016/j.phymed.2021.153709] [Reference Citation Analysis]
17 Kato J, Yoshida T, Niwa T. Blue Polypoid Colorectal Lesions in a Woman With Ulcerative Colitis Taking Qing-Dai. Clin Gastroenterol Hepatol 2016;14:A32. [PMID: 27094581 DOI: 10.1016/j.cgh.2016.04.021] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Shimizu T, Takagi C, Sawano T, Eijima Y, Nakatani J, Fujita T, Tanaka H. Indigo enhances wound healing activity of Caco-2 cells via activation of the aryl hydrocarbon receptor. J Nat Med 2021;75:833-9. [PMID: 33963491 DOI: 10.1007/s11418-021-01524-y] [Reference Citation Analysis]
19 Caron B, Sandborn WJ, Schreiber S, Panaccione R, Danese S, Peyrin-Biroulet L. Drug development for ulcerative proctitis: current concepts. Gut 2021;70:1203-9. [PMID: 33789968 DOI: 10.1136/gutjnl-2021-324108] [Reference Citation Analysis]
20 Wen J, Teng B, Yang P, Chen X, Li C, Jing Y, Wei J, Zhang C. The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice. J Ethnopharmacol. 2016;188:31-38. [PMID: 27132718 DOI: 10.1016/j.jep.2016.04.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Caron B, Sandborn WJ, Panaccione R, Schreiber S, Hart A, Solitano V, Danese S, Peyrin-Biroulet L. Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review. J Crohns Colitis 2021:jjab218. [PMID: 34850857 DOI: 10.1093/ecco-jcc/jjab218] [Reference Citation Analysis]
22 Suzuki H, Kaneko T, Mizokami Y, Narasaka T, Endo S, Matsui H, Yanaka A, Hirayama A, Hyodo I. Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis. World J Gastroenterol 2013; 19(17): 2718-2722 [PMID: 23674882 DOI: 10.3748/wjg.v19.i17.2718] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
23 Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol 2016;51:853-61. [DOI: 10.1007/s00535-016-1220-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
24 Liang YN, Yu JG, Zhang DB, Zhang Z, Ren LL, Li LH, Wang Z, Tang ZS. Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community. Molecules. 2019;24. [PMID: 31726738 DOI: 10.3390/molecules24224086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
25 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mosli MH, Feagan BG, Sandborn WJ, Dʼhaens G, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, Macdonald JK, Vandervoort MK, Geboes K, Levesque BG. Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices. Inflamm Bowel Dis 2014;20:564-75. [PMID: 24412993 DOI: 10.1097/01.MIB.0000437986.00190.71] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 9.1] [Reference Citation Analysis]
27 Kondo S, Araki T, Okita Y, Yamamoto A, Hamada Y, Katsurahara M, Horiki N, Nakamura M, Shimoyama T, Yamamoto T, Takei Y, Kusunoki M. Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases. Clin J Gastroenterol 2018;11:268-72. [DOI: 10.1007/s12328-018-0851-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]